Tirzepatide reduced sleep apnoea severity by up to nearly two-thirds in adults living with OSA and obesity
top of page
Browse by category
Search
Eli Lilly and Company has announced positive topline results from the SURMOUNT-OSA phase 3 clinical trials that showed tirzepatide...
Ultra-processed foods increase the risk of all-cause mortality and to 32 damaging health outcomes
Highly suggestive (class II) evidence indicates that higher exposure to ultra-processed foods is associated with an increased risk of 32...
Disrupted cellular function of “cleaning cells” may explain why some people with obesity develop T2DM
Disrupted function of “cleaning cells” in the body may help to explain why some people with obesity develop type 2 diabetes, while others...
The role of growth hormone secretagogue receptor in obesity-related chronic inflammation
A team comprised primarily of Texas A&M AgriLife Research scientists has made an important discovery that could lead to a novel treatment...
Individuals with obesity are more likely to have benign blood condition MGUS
Individuals with obesity are more likely to have monoclonal gammopathy of undetermined significance (MGUS), a benign blood condition that...
Increased concentration of leptin key to antipsychotic-drug–induced obesity
An increased concentration of the hormone leptin in fat cells is believed to be responsible for weight gain associated with antipsychotic...
Skye to develop nimacimab for the treatment of obesity by targeting the endocannabinoid system
Skye Bioscience, a pharmaceutical company developing drugs targeting the endocannabinoid system (ECS), has announced that it plans to...
Browse by tag
bottom of page